Bengt Hallengren

affiliated with the university
More filtering options
  1. 2019
  2. Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism: A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey

    Törring, O., Watt, T., Sjölin, G., Byström, K., Abraham-Nordling, M., Calissendorff, J., Cramon, P. K., Filipsson Nyström, H., Bengt Hallengren, Holmberg, M., Khamisi, S., Mikael Lantz & Wallin, G., 2019, In : Thyroid : official journal of the American Thyroid Association. 29, 3, p. 322-331 10 p.

    Research output: Contribution to journalArticle

  3. 2016
  4. Adjuvant Treatment of Graves' Disease with Diclofenac: Safety, Effects on Ophthalmopathy and Antibody Concentrations

    Mikael Lantz, Calissendorff, J., Träisk, F., Tallstedt, L., Tereza Planck, Törring, O., Bengt Hallengren & Peter Åsman, 2016 Mar, In : European Thyroid Journal. 5, 1, p. 50-6

    Research output: Contribution to journalArticle

  5. 2015
  6. 2014
  7. Smoking induces overexpression of immediate early genes in active Graves' ophthalmopathy.

    Tereza Planck, Bushra Shahida, Parikh, H., Ström, K., Peter Åsman, Håkan Brorson, Bengt Hallengren & Mikael Lantz, 2014, In : Thyroid. 24, 10, p. 1524-1532

    Research output: Contribution to journalArticle

  8. 2013
  9. 2012
  10. 2011
  11. Gene Expression in Graves' Ophthalmopathy and Arm Lymphedema: Similarities and Differences.

    Tereza Planck, Parikh, H., Håkan Brorson, Mårtensson, T., Peter Åsman, Leif Groop, Bengt Hallengren & Mikael Lantz, 2011, In : Thyroid. 21, p. 663-674

    Research output: Contribution to journalArticle

  12. Incidence of hyperthyroidism in Sweden

    Abraham-Nordling, M., Bystrom, K., Torring, O., Mikael Lantz, Berg, G., Calissendorff, J., Nystrom, H. F., Jansson, S., Jorneskog, G., Karlsson, F. A., Nystrom, E., Ohrling, H., Orn, T., Bengt Hallengren & Wallin, G., 2011, In : European Journal of Endocrinology. 165, 6, p. 899-905

    Research output: Contribution to journalArticle

  13. Maternal Autoimmune Thyroid Disease and the Fetal Immune System.

    Svensson, J., Oderup, C., Silver, C., Uvebrant, K., Bengt Hallengren, Ericsson, U. B., Arvastsson, J., Danska, J. S., Mikael Lantz & Corrado Cilio, 2011, In : Experimental and Clinical Endocrinology & Diabetes. 119, 7, p. 445-450

    Research output: Contribution to journalArticle

  14. 2010
  15. Thyroid-associated ophthalmopathy; quality of life follow-up of patients randomized to treatment with antithyroid drugs or radioiodine

    Abraham-Nordling, M., Wallin, G., Traisk, F., Berg, G., Calissendorff, J., Bengt Hallengren, Hedner, P., Mikael Lantz, Nystrom, E., Asman, P., Lundell, G. & Torring, O., 2010, In : European Journal of Endocrinology. 163, 4, p. 651-657

    Research output: Contribution to journalArticle

  16. 2009
  17. Pregnant Women on Thyroxine Substitution Are Often Dysregulated in Early Pregnancy.

    Bengt Hallengren, Mikael Lantz, Andréasson, B. & Grennert, L., 2009, In : Thyroid. 19, p. 391-394

    Research output: Contribution to journalArticle

  18. Thyroid-Associated Ophthalmopathy after Treatment for Graves' Hyperthyroidism with Antithyroid Drugs or Iodine-131.

    Träisk, F., Tallstedt, L., Abraham-Nordling, M., Andersson, T., Berg, G., Calissendorff, J., Bengt Hallengren, Hedner, P., Mikael Lantz, Nyström, E., Ponjavic, V., Taube, A., Törring, O., Wallin, G., Peter Åsman & Lundell, G., 2009, In : The Journal of clinical endocrinology and metabolism. 94, p. 3700-3707

    Research output: Contribution to journalArticle

  19. 2008
  20. Incidence of hyperthyroidism in Stockholm, Sweden, 2003-2005

    Abraham-Nordling, M., Törring, O., Mikael Lantz, Bengt Hallengren, Ohrling, H., Lundell, G., Calissendorff, J., Jörneskog, G. & Wallin, G., 2008, In : European Journal of Endocrinology. 158, 6, p. 823-827

    Research output: Contribution to journalArticle

  21. 2007
  22. COX-2 and SCD, markers of inflammation and adipogenesis, are related to disease activity in Graves' ophthalmopathy

    Tereza Planck, de Capretz, A., Parikh, H., Frenander, C., Peter Åsman, Åberg, M., Leif Groop, Bengt Hallengren & Mikael Lantz, 2007, In : Thyroid. 17, 6, p. 511-517

    Research output: Contribution to journalArticle

  23. Sköldkörteln - tyreoidea

    Bengt Hallengren & Karlsson, A., 2007, Endokrinologi. Werner, S. (ed.). Liber, p. 93

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  24. Thyrostimulin (a TSH-like Hormone) Expression in Orbital and Thyroid Tissue.

    Mikael Lantz, Tereza Planck, Capretz, A., Nilsson, E., Frenander, C., Bondeson, A-G., Martin Ridderstråle, Åberg, M., Peter Åsman, Leif Groop & Bengt Hallengren, 2007, In : Thyroid. 17, 2, p. 113-118

    Research output: Contribution to journalArticle

  25. Tyreoideasjukdomar

    Bengt Hallengren, 2007, Läkemedelsboken 2007/2008. Bogentoft, S. (ed.). Apoteket AB, p. 511

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  26. 2006
  27. Sarcoidosis and Autoimmunity: Evidence of Differential Associations with HLA Class II Markers

    Papadopoulos, K. I., Wassmuth, R., Sponsel, T., Sjöberg, K. & Bengt Hallengren, 2006, In : International Journal of Endocrinology and Metabolism. 4, 1, p. 13-18

    Research output: Contribution to journalArticle

  28. 2005
  29. Tyreoideasjukdomar

    Bengt Hallengren, 2005, Läkemedelsboken. Bogentoft, S. (ed.). Apoteket AB, p. 491

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  30. 2004
  31. Tyreoideasjukdomar

    Bengt Hallengren, 2004, Obstetrisk öppenvård. Marsál, K. & Grennert, L. (eds.). Liber, p. 148

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  32. 2003
  33. Endokrin oftalmopati. Ett svårbehandlat kliniskt problem

    Tallstedt, L., Bengt Hallengren & Nyström, E., 2003, In : Läkartidningen. 100, 3, p. 114-119

    Research output: Contribution to journalArticle

  34. Sköldkörteln- tyreoidea

    Bengt Hallengren & Karlsson, A., 2003, Endokrinologi. Werner, S. (ed.). Liber, p. 88

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  35. Tyreoideasjukdomar

    Bengt Hallengren, 2003, Läkemedelsboken. Apoteket AB, p. 524-535

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  36. Vanligt, kvinnligt och lättbehandlat. Om primär hypotyreos - en okänd folksjukdom

    Nyström, E., Bengt Hallengren, Lindstedt, G. & Winsa, B., 2003, In : Läkartidningen. 100, 8, p. 610-617

    Research output: Contribution to journalArticle

  37. 2002
  38. 2001
  39. Effects and serum levels of glibenclamide and its active metabolites in patients with type 2 diabetes

    Jönsson, A., Bengt Hallengren, Rydberg, T. & Melander, A., 2001, In : Diabetes, Obesity and Metabolism. 3, 6, p. 403-409

    Research output: Contribution to journalArticle

  40. 2000
  41. 1999
  42. 1996
  43. Islet cell and glutamic acid decarboxylase antibodies in hyperthyroid patients: At diagnosis and following treatment

    B. Hallengren, Falorni, A., M. Landin-Olsson, Å Lernmark, Papadopoulos, K. I. & Sundkvist, G., 1996 Jan 1, In : Journal of Internal Medicine. 239, 1, p. 63-68

    Research output: Contribution to journalArticle

  44. 1992
  45. 80-year-old men have elevated plasma concentrations of catecholamines but decreased plasma renin activity and aldosterone as compared to young men

    B Hallengren, S Elmståhl, Galvard, H., Jerntorp, P., Manhem, P., H Pessah-Rasmussen & Stavenow, L., 1992 Dec, In : Aging (Milan, Italy). 4, 4, p. 341-5 5 p.

    Research output: Contribution to journalArticle

  46. 1989